Jill S. Barnholtz-Sloan, PhD
Professor and Associate Director for Data Sciences/Translational Informatics
email@example.com | 216.368.1506 | Wolstein Research Bldg. 2526
Sally S. Morley Designated Professor in Brain Tumor Research, Department of Population and Quantitative Health Sciences
Associate Director for Data Sciences/Translational Informatics, Case Comprehensive Cancer Center and Cleveland Institute for Computational Biology
Case Western Reserve University School of Medicine
Director, Research Health Analytics and Informatics
University Hospitals Health System (UHHS)
Director, Cleveland Center for Health Outcomes Research (CCHOR)
Case Western Reserve University School of Medicine
Ph.D., 2000, Biostatistics, University of Texas Health Science Center at Houston (UTHealth) School of Public Health
M.S., 1995, Statistics, University of Texas at Austin
B.S., 1994, Mathematics, University of Florida
Dr. Barnholtz-Sloan is multi-disciplinary researcher trained in biostatistics, population genetics, and human genetics. Her role in team science has been essential for multiple, successful multi-disciplinary research projects. She is the PI of the Ohio Brain Tumor Study (OBTS), which has served as a multi-site tissue source site for The Cancer Genome Atlas (TCGA). She is also the scientific PI of the Central Brain Tumor Registry for the United States (CBTRUS). She has extensive experience with multi-site, brain tumor, patient recruitment and bio specimen collection, storage, and clinical annotation. She has multiple roles in the Case Western (CWRU) School of Medicine and the University Hospitals Health System (UHHS), which all focus on optimizing the use of data and analytics to advance health care.
At CWRU she is the Associate Director for Data Sciences at the Case Comprehensive Cancer Center and the Associate Director for Translational Informatics for the Cleveland Institute of Computational Biology. In these roles, she advances research endeavors by advocating for and assisting researchers in obtaining access to and using large health datasets (publicly available or controlled access) to answer research questions. Dr. Barnholtz-Sloan also aids investigators in the use of secure database infrastructure needed for human subjects’ research, the implementation of robust study designs, as well as the interpretation of results. These efforts aim to reduce the burden and barriers researchers may encounter in gaining access to and analyzing “big data”, enabling them to think about and perform research that has previously not been pursued.
As the Director for Research Health Analytics and Informatics at UHHS, she facilitates access to and analysis of UHHS data. Dr. Barnholtz-Sloan’s efforts focus on aiding clinicians in utilizing “big data” to impact clinical outcomes modeling that can drive both health operations and clinical decision making.
Dr. Barnholtz-Sloan is also Director of the Cleveland Center for Health Outcomes Research (CCHOR), which was established in the summer of 2018. The goal of the CCHOR is to integrate, innovate, and optimize the use of “big data”. CCHOR facilitates access to datasets and helps support analysis to test hypotheses and drive discoveries, facilitating understanding and impact on health.
Together, all of these roles draw upon her extensive experience in hypothesis development, study design and statistical analysis for studies of various phenotypes in humans and animals, and analysis of all types of high throughput “omics” and clinical outcomes data.
American Association of Cancer Research
North American Association for Cancer Registries
Society for Neuro Oncology
- Davis, FG, Smith, TR, Gittleman, HR, Ostrom, QT, Kruchko, C, Barnholtz-Sloan, JS. Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995-2015. Neuro-oncology 2019; : . PubMed PMID:31786602 .
- Ascha, MS, Wang, JF, Kumthekar, P, Sloan, AE, Kruchko, C, Barnholtz-Sloan, JS. Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases. Sci Rep 2019; 9 (1): 17792. PubMed PMID:31780762 PubMed Central PMC6882803.
- Barthel, FP, Johnson, KC, Varn, FS, Moskalik, AD, Tanner, G, Kocakavuk, E, Anderson, KJ, Abiola, O, Aldape, K, Alfaro, KD, Alpar, D, Amin, SB, Ashley, DM, Bandopadhayay, P, Barnholtz-Sloan, JS, Beroukhim, R, Bock, C, Brastianos, PK, Brat, DJ, Brodbelt, AR, Bruns, AF, Bulsara, KR, Chakrabarty, A, Chakravarti, A, Chuang, JH, Claus, EB, Cochran, EJ, Connelly, J, Costello, JF, Finocchiaro, G, Fletcher, MN, French, PJ, Gan, HK, Gilbert, MR, Gould, PV, Grimmer, MR, Iavarone, A, Ismail, A, Jenkinson, MD, Khasraw, M, Kim, H, Kouwenhoven, MCM, LaViolette, PS, Li, M, Lichter, P, Ligon, KL, Lowman, AK, Malta, TM, Mazor, T, McDonald, KL, Molinaro, AM, Nam, DH, Nayyar, N, Ng, HK, Ngan, CY, Niclou, SP, Niers, JM, Noushmehr, H, Noorbakhsh, J, Ormond, DR, Park, CK, Poisson, LM, Rabadan, R, Radlwimmer, B, Rao, G, Reifenberger, G, Sa, JK, Schuster, M, Shaw, BL, Short, SC, Smitt, PAS, Sloan, AE, Smits, M, Suzuki, H, Tabatabai, G, Van Meir, EG, Watts, C, Weller, M, Wesseling, P, Westerman, BA, Widhalm, G, Woehrer, A, Yung, WKA, Zadeh, G, Huse, JT, De Groot, JF, Stead, LF, Verhaak, RGW, GLASS Consortium. Longitudinal molecular trajectories of diffuse glioma in adults. Nature 2019; 576 (7785): 112-120. PubMed PMID:31748746 .
- Ascha, MS, Funk, K, Sloan, AE, Kruchko, C, Barnholtz-Sloan, JS. Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study. Clin. Exp. Metastasis 2019; : . PubMed PMID:31705229 .
- Wright, CH, Wright, J, Cioffi, G, Hdeib, A, Kasliwal, MK, Kruchko, C, Barnholtz-Sloan, JS, Sloan, AE. Association of cancer center type with treatment patterns and overall survival for patients with sacral and spinal chordomas: an analysis of the National Cancer Database from 2004 to 2015. J Neurosurg Spine 2019; : 1-10. PubMed PMID:31675723 .
- Ostrom, QT, Cioffi, G, Gittleman, H, Patil, N, Waite, K, Kruchko, C, Barnholtz-Sloan, JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro-oncology 2019; 21 (Supplement_5): v1-v100. PubMed PMID:31675094 PubMed Central PMC6823730.
- Saunders, CN, Cornish, AJ, Kinnersley, B, Law, PJ, Claus, EB, Il'yasova, D, Schildkraut, J, Barnholtz-Sloan, JS, Olson, SH, Bernstein, JL, Lai, RK, Chanock, S, Rajaraman, P, Johansen, C, Jenkins, RB, Melin, BS, Wrensch, MR, Sanson, M, Bondy, ML, Houlston, RS. Lack of association between modifiable exposures and glioma risk: A Mendelian randomisation analysis. Neuro-oncology 2019; : . PubMed PMID:31665421 .
- Ostrom, QT, Kruchko, C, Barnholtz-Sloan, JS. Pilocytic astrocytoma: Where do they belong in cancer reporting? Neuro-oncology 2019; : . PubMed PMID:31637436 .
- Gittleman, H, Sloan, AE, Barnholtz-Sloan, JS. An independently validated survival nomogram for lower grade glioma. Neuro-oncology 2019; : . PubMed PMID:31621885 .
- Gittleman, H, Cioffi, G, Chunduru, P, Molinaro, AM, Berger, MS, Sloan, AE, Barnholtz-Sloan, JS. An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival. Neurooncol Adv ; 1 (1): vdz007. PubMed PMID:31608326 PubMed Central PMC6777501.